Petros Grivas MD, PhD
Advertisement
Professor, Clinical Research Division, Fred Hutch, Clinical Director, Genitourinary Cancers Program, Fred Hutch
Articles by Petros Grivas MD, PhD
Advertisement
Latest Updated Articles
Park and Grivas Expand on Treatment Updates in Bladder CancerPublished: August 7th 2024 | Updated:
Real-World Data With Avelumab Maintenance Therapy in Metastatic Urothelial CarcinomaPublished: May 11th 2023 | Updated:
Patient Fitness and the Doublet vs Triplet Debate in Metastatic Castration-Sensitive Prostate CancerPublished: June 30th 2025 | Updated:
Metastatic Urothelial Carcinoma: Number of Frontline Chemotherapy CyclesPublished: May 4th 2023 | Updated:
- Emerging Trials and the Future of Biomarker-Driven Therapy in Metastatic Castration-Sensitive Prostate Cancer
Published: July 9th 2025 | Updated:
- Clinical Trial Data With Perioperative Therapy in MIBC: Bladder BRIDGister
Published: April 20th 2023 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
Nonresponse to Bridging Therapy and Peak ALC After Cilta-Cel Are Associated With Neurotoxicity, NRM in Myeloma
2
FDA Underscores Risks Associated With DPD Deficiency and Capecitabine/5-FU Use in Cancer Care
3
Long-Term Cilta-Cel Data Show Low Rates of PFS Events in Standard-Risk R/R Myeloma
4
Orca-T With Reduced-Intensity Conditioning Yields Robust Efficacy in Hematologic Malignancies
5